SYRE vs VRTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

SYRE

66.4
AI Score
VS
SYRE Wins

VRTX

38.2
AI Score

Investment Advisor Scores

SYRE

Sep 12, 2026
66score
Recommendation
HOLD

VRTX

Sep 12, 2026
38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric SYRE VRTX Winner
Forward P/E 0 24.3309 Tie
PEG Ratio 0 1.5897 Tie
Revenue Growth 0.0% 12.5% VRTX
Earnings Growth -99.7% 8.0% VRTX
Tradestie Score 66.4/100 38.2/100 SYRE
Profit Margin 0.0% 35.0% VRTX
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD SELL SYRE

Relative Price Performance (Last 90 Days)

SYRE 1M: -13.0% · 3M: +12.2% VRTX 1M: -2.0% · 3M: +15.8%

Current Technical Phase

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $90.60

VRTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.1 · Price: $515.44

Fundamentals Snapshot

Metric SYRE VRTX
Market Cap
Forward P/E -25.7 25.6
Trailing P/E 30.4
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5%
Operating Margin 0.0% 0.4%
EPS -1.96 16.93
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.